Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.

Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J.

Arch Gen Psychiatry. 2008 Jan;65(1):102-14. doi: 10.1001/archgenpsychiatry.2007.16.

PMID:
18180434
2.

[Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].

Emond V, Joyal C, Poissant H.

Encephale. 2009 Apr;35(2):107-14. doi: 10.1016/j.encep.2008.01.005. Epub 2008 Jul 7. Review. French.

PMID:
19393378
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
4.

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.

Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Review.

PMID:
19673602
7.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
9.

Osmotic, controlled-release methylphenidate for the treatment of ADHD.

Coghill D, Seth S.

Expert Opin Pharmacother. 2006 Oct;7(15):2119-38. Review.

PMID:
17020437
10.

Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.

Prince J.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S39-45. doi: 10.1097/JCP.0b013e318174f92a. Review.

PMID:
18480676
11.
12.

Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.

Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM.

Harv Rev Psychiatry. 2013 May-Jun;21(3):151-62. doi: 10.1097/HRP.0b013e318293749e. Review.

13.

Recent advances in structural and functional brain imaging studies of attention-deficit/hyperactivity disorder.

Kelly AM, Margulies DS, Castellanos FX.

Curr Psychiatry Rep. 2007 Oct;9(5):401-7. Review.

PMID:
17915080
14.

Remission versus response as the goal of therapy in ADHD: a new standard for the field?

Steele M, Jensen PS, Quinn DM.

Clin Ther. 2006 Nov;28(11):1892-908. Review.

PMID:
17213010
15.

Safety of therapeutic methylphenidate in adults: a systematic review of the evidence.

Godfrey J.

J Psychopharmacol. 2009 Mar;23(2):194-205. doi: 10.1177/0269881108089809. Epub 2008 May 30. Review.

PMID:
18515459
16.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
17.

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Fowler JS, Ding YS.

Biol Psychiatry. 2005 Jun 1;57(11):1410-5. Epub 2005 Jan 12. Review.

PMID:
15950015
18.

Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder.

Lange KW, Tucha L, Walitza S, Gerlach M, Linder M, Tucha O.

J Neural Transm Suppl. 2007;(72):249-59. Review.

PMID:
17982901
19.

[Central stimulants in adults with AD/HD. Do they help?].

Lie N.

Tidsskr Nor Laegeforen. 1998 Nov 10;118(27):4223-7. Review. Norwegian.

PMID:
9857806
20.

A possible pathophysiologic substrate of attention deficit hyperactivity disorder.

Heilman KM, Voeller KK, Nadeau SE.

J Child Neurol. 1991;6 Suppl:S76-81. Review.

PMID:
2002218

Supplemental Content

Support Center